Nestlé Launches First Product With HMOs In China
Nestlé has announced the launch of a ‘growing-up milk’ solution containing HMOs (Human Milk Oligosaccharides) for early life nutrition, in mainland China.
The product, which has been launched under the Wyeth illuma brand, follows on from the recent approval for the use of such bioactive ingredients by China’s National Health Commission.
HMOs are the third most abundant solid component in human breast milk, after lactose and lipids, Nestlé said, with the new product containing two of the three major types of HMOs, as well as healthy lipids and proteins that ‘play a role in gut and immune health and cognitive development’.
The new product will be manufactured at Nestlé’s factory in Suzhou, mainland China.
The first launch of HMO products in China brings the benefits of HMOs and 35 other vital ingredients in the illuma growing up milk to young children – the company reported, adding that the introduction of the illuma growing-up milk extends Nestlé’s expertise in HMO science throughout its formula brand lineup. With the recent launch of the Sinergity brand, Nestlé introduced a proprietary blend featuring a particular probiotic combined with six age-adapted human milk oligosaccharides (HMOs) to promote infant development and unlock specific health benefits.
Related news
Choking hazard pacifiers and toxic raincoats: EU investigates flood of Temu and Shein products
Pacifiers that can cause choking, sunglasses without UV filters, cosmetics…
Read more >Retail kept its position in terms of employer attractiveness
Honouring Hungary’s most attractive employers, the Randstad Awards have been…
Read more >Family businesses are placing an unprecedented emphasis on innovation
Innovation is playing a leading role in the lives of…
Read more >Related news
Carrefour sells Italian branch to NewPrinces Group
Carrefour has entered into a binding agreement with NewPrinces Group…
Read more >